Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential
Biomolecules · 04.08.2025 · 15 (8) · 1119
DOI: 10.3390/biom15081119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.08.2025. Verfasst von Sofía Fernández-Hernández und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Skien Hospital, Vestfold og Telemark, Ulefossvegen 55, 3710 Skien, Norway. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON PATHFINDER EUROPE 2023- "European Innovation Council" program, AESPANC-ACANPAN, HORIZON PATHFINDER EUROPE.
Abstract (Originalsprache)
Colorectal cancer (CRC) is not only the third most common cancer worldwide, with 1.1 million new cases per year; it is also the second leading cause of cancer death. However, mortality has decreased since 2012 due to early detection programs and better therapeutic approaches. While many patients are diagnosed at an early stage, there is up to 50% relapse after optimal initial treatment. Therefore, it is crucial to explore the mechanism underlying the development of recurrences and metastasis. It is known that tumors release dormant cells that escape chemotherapy and nest in a target organ without proliferating. Under certain circumstances that are not yet entirely clear, they can be activated and metastasize. Therefore, the objective of this work is to explore the detailed mechanisms of dormancy, including early detection of recurrence and therapeutic approaches for the treatment of CRC. The specific objectives are to determine biomarkers that may be useful in identifying dormant cells to detect minimal residual disease (MRD) after surgery and predicting disease progression, as well as evaluating biomarkers that are susceptible to therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Skien Hospital, Vestfold og Telemark, Ulefossvegen 55, 3710 Skien, Norway.
- Translational Oncology Division, OncoHealth Institute, Health Research Institute Fundación Jimenez Diaz, Fundación Jimenez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
- New Therapies Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD), Avda. Reyes Católicos, 2, 28040 Madrid, Spain.
- Department of Medical Oncology, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
- Area of Physiology, Department of Basic Health Sciences, Faculty of Health Sciences, Rey Juan Carlos University, 28922 Madrid, Spain.
ORCID-Profile: Javier Martinez-Useros
Förderung
- HORIZON PATHFINDER EUROPE 2023- "European Innovation Council" program
- AESPANC-ACANPAN
- HORIZON PATHFINDER EUROPE
- Spanish Pancreatic Cancer Association
Zitieren
APA
Fernández-Hernández, S., Hidalgo-León, M. Á., Lacalle-González, C., Olivera-Salazar, R., Ochieng' Otieno, M., García-Foncillas, J., & Martinez-Useros, J. (2025). Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential. Biomolecules, 15(8), 1119. https://doi.org/10.3390/biom15081119
Vancouver
Fernández-Hernández S, Hidalgo-León MÁ, Lacalle-González C, Olivera-Salazar R, Ochieng' Otieno M, García-Foncillas J, et al. Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential. Biomolecules. 2025;15(8):1119. doi:10.3390/biom15081119
BibTeX
@article{FernndezHernndez2025,
author = {Fernández-Hernández, Sofía and Hidalgo-León, Miguel Ángel and Lacalle-González, Carlos and Olivera-Salazar, Rocío and Ochieng' Otieno, Michael and García-Foncillas, Jesús and Martinez-Useros, Javier},
title = {Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {8},
pages = {1119},
doi = {10.3390/biom15081119}
}
EUVIMED